Skip to main content
. 2021 Jan 14;11:52. doi: 10.1038/s41398-020-01189-3

Fig. 2. Select phenolic metabolites derived from FDP inhibit NLRP3-dependent production of IL-1β.

Fig. 2

(A) Secretion of IL-1β from THP-1 macrophages pre-treated with phenolic metabolites and then stimulated with LPS and ATP. MG: malvidin-glucoside. DG: delphinidin-glucoside. QG: quercetin-glucuronide. CG: Cyanidin-glucoside. HBA: 3-hydroxybenzoic acid. HPPA: 3-(3′-hydroxyphenyl)propionic acid. HPA: 3-hydroxyphenylacetic acid. DHCA: 3-(3′, 4′-dihydroxyphenyl)propionic acid. HPVA: 5-(4’-hydroxyphenyl)valeric acid. (B) Release of LDH from THP-1 macrophages pre-treated with phenolic metabolites then stimulated with LPS and ATP. (C) Secretion of IL-1β from mouse primary microglia pre-treated with phenolic metabolites and then stimulated with LPS and ATP. (D) Secretion of IL-1β in mouse primary microglia pre-treated with increasing concentrations of MG and stimulated with LPS and ATP. (E) Calculation of IC50 of IL-1β secretion in response to MG pretreatment and LPS and ATP stimulation. (F) Cytotoxicity of microglial cultures in response to MG pre-treatment, measured by LDH release. N = 3–4 biological replicates/group, performed in duplicate. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by Student’s t-test.